Features associated with causes of first admission of patients with SLE. Values are mean ± SD, median (interquartile range), or n (%).
| Features | Active SLE, n = 59 | SLE Damage, n = 30 | Other Comorbidities, n = 22 | Infection, n = 47 | Incidental, n = 89 |
|---|---|---|---|---|---|
| Age, yrs† | 34.68 ± 12.64 | 43.90 ± 18.39 | 55.13 ± 23.02 | 43.53 ± 15.05 | 47.61 ± 18.26 |
| SLE duration, yrs† | 5.92 ± 6.70 | 17.23 ± 11.87 | 16.60 ± 10.53 | 15.20 ± 12.05 | 16.23 ± 13.79 |
| SDI† | 0 (0–1) | 3 (1–4) | 2 (0–3) | 2 (0–4) | 1 (0–3) |
| Antimalarial-treated | 34 (56.7) | 13 (43.3) | 10 (45.5) | 19 (40.4) | 46 (52.3) |
| Prednisone-treated† | 34 (56.7) | 21 (70.0) | 9 (40.9) | 39 (83.0) | 54 (61.4) |
| Prednisone dose, mg/day† | 18.56 ± 16.45 | 11.05 ± 8.11 | 6.67 ± 2.17 | 12.02 ± 11.09 | 11.69 ± 8.06 |
| Immunosuppressive-treated† | 22 (36.7) | 15 (50.0) | 3 (13.6) | 23 (48.9) | 30 (34.1) |
↵† p < 0.05 from ANOVA tests for mean difference, Kruskal-Wallis tests for median, and chi-square tests for percentage differences. SLE: systemic lupus erythematosus; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.